Indian drug firms cheer dexamethasone efficacy on severe COVID-19 patients

M P Gupta, general manager of Mahima Lifesciences, a Chandigarh-based
steroid API maker, said the company was expecting a jump in raw
material costs and possible supply disruption if demand goes up.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-drug-firms-cheer-dexamethasone-efficacy-on-severe-covid-19-patients/articleshow/76437755.cms

Comments

Popular posts from this blog

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online

Biotecnika Times Newsletter 30.11.2021 CSIR-IGIB Rs 1.5 Lakh pm Pay Job, ACTREC High Pay

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission